Physician profile
Maureen Anne Brady
NPI 1295454072
$1,614.80
in general payments reported to CMS, 2019-2025
15 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $391 · 2024: $721 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $374.58 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Novartis Pharmaceuticals Corporation | $284.21 | 2024-2025 | |
| Novo Nordisk INC | $174.81 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $157.69 | 2024-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $128.56 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.42 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Merck Sharp & Dohme LLC | $70.53 | 2023-2024 | Belsomra, Steglatro, Capvaxive |
| Abbvie INC. | $61.52 | 2023-2025 | |
| Axsome Therapeutics, INC. | $59.53 | 2025 | Auvelity |
| Pfizer INC. | $55.76 | 2024-2025 | |
| Astellas Pharma US INC | $52.09 | 2023-2024 | Veozah |
| Phathom Pharmaceuticals, INC. | $31.56 | 2024-2025 | Voquezna |
| Amgen INC. | $22.98 | 2025 | Evenity |
| Idorsia Pharmaceuticals US INC | $18.13 | 2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $15.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.